Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.

CD Genomics, a globally distinguished pioneer in genomic technologies, declared today the induction of their innovative LncRNA Microarray Service, affording scientists an avant-garde solution for ...

Abstract: The last few years have witnessed exponential rise in breast cancer disease. The increasing mortality rate due to the lack of earlier diagnosis has alarmed healthcare industry to develop ...

The differentially expressed genes were categorized according to known molecular functions. A proportion was associated with transcriptional control or had unknown functions: 49.0% (246/502) in DSCL ...

MUUMI is an R package designed to enable the integration and interpretation of multi-omics data by combining statistical meta-analysis with network-based methodologies. It enables robust ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

An international research team led by the University of Vienna has developed a new version of RNA building blocks with higher chemical reactivity and photosensitivity, significantly reducing the ...